Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) 74th Annual Scientific Session and Expo in Chicago, March 29-31.

Edwards Lifesciences EW has announced one-year, real-world data on its SAPIEN 3 Ultra RESILIA valve ... stenosis. Additionally, new evidence was presented on Edwards’ portfolio of transcatheter ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as the world’s first transfemoral transcatheter mitral valve replacement ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful ...

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery. The condition is more common in women and younger patients ...

“Aortic valve stenosis” is an often-overlooked condition and a growing health concern in ageing societies such as Thailand. With an increasing elderly population and a rise in age-related ...

Transcatheter aortic valve implantation has been established as an alternative treatment option for patients with severe aortic stenosis presenting ... the treatment of mitral regurgitation ...

Its total funding is more than $200 million. Cardiac Dimensions is targeting a condition called mitral valve regurgitation, which involves the leakage of blood through the heart’s mitral valve ...

The aortic valve is a door ... problem where the pressure gradient between the heart and aorta increases above a mean of 40 mm Hg, which is called severe aortic stenosis. However, due to various ...

The pathophysiologic changes caused by a calcified aortic valve are the same as those caused by other forms of aortic stenosis and are related to the pressure gradient that develops between the ...